Medline Inc. Class A Common Stock
Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front … Read more
Medline Inc. Class A Common Stock (MDLN) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.037x
Based on the latest financial reports, Medline Inc. Class A Common Stock (MDLN) has a cash flow conversion efficiency ratio of 0.037x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($636.00 Million) by net assets ($17.14 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Medline Inc. Class A Common Stock - Cash Flow Conversion Efficiency Trend (2023–2024)
This chart illustrates how Medline Inc. Class A Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Medline Inc. Class A Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medline Inc. Class A Common Stock ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bank Rakyat
PINK:BKRKY
|
0.124x |
|
Nutrien Ltd
NYSE:NTR
|
-0.017x |
|
Kimberly-Clark Corporation
NYSE:KMB
|
0.532x |
|
Intact Financial Corporation
PINK:IFCZF
|
0.048x |
|
Orix Corp Ads
NYSE:IX
|
0.129x |
|
ResMed Inc
NYSE:RMD
|
0.054x |
|
Alcon Inc.
XETRA:2U3
|
N/A |
|
Orange SA
XETRA:FTE
|
0.144x |
Annual Cash Flow Conversion Efficiency for Medline Inc. Class A Common Stock (2023–2024)
The table below shows the annual cash flow conversion efficiency of Medline Inc. Class A Common Stock from 2023 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $16.52 Billion | $1.77 Billion | 0.107x | +7.86% |
| 2023-12-31 | $16.98 Billion | $1.69 Billion | 0.099x | -- |